Zobrazeno 1 - 10 of 111 pro vyhledávání: '"William M. Glazer"'
1
Tactics and technologies to manage nonadherence in patients with schizophrenia
Autor: William M. Glazer, Mathew J. Byerly
Publikováno v: Current Psychiatry Reports. 10:359-369
The occurrence of treatment nonadherence among patients with schizophrenia is clinically significant. However, studies show that clinicians do not make systematic efforts to identify and monitor it over time. This paper reviews the various tactics fo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b745b5e09d2305a2b75210c884110a5
https://doi.org/10.1007/s11920-008-0057-7
Zobrazit plný text záznamu
2
Are We Treating Schizophrenia Effectively? Understanding the Primary Outcomes of the CATIE Study
Autor: Leslie Citrome, Robert R Conley, William M Glazer
Publikováno v: CNS Spectrums. 11:1-16
The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study for schizophrenia was designed to independently evaluate the effectiveness of antipsychotic treatment in “real-world” patients. To assess the effectiveness of the conve
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb9d5af9b2ce20237c42d219a596c241
https://doi.org/10.1017/s1092852900025748
Zobrazit plný text záznamu
3
Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol
Autor: Hal Morgenstern, Roy N. Tamura, William M. Glazer, Kevin J. Ferguson, Mary Anne Dellva, Gary D. Tollefson, Charles M. Beasley
Publikováno v: British Journal of Psychiatry. 174:23-30
BackgroundTardive dyskinesia is important in the side-effect profile of antipsychotic medication.AimsThe development of tardive dyskinesia was evaluated in patients treated with double-blind, randomly assigned olanzapine or haloperidol for up to 2.6
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f70195253b5ea9e3c261484a971b8403
https://doi.org/10.1192/bjp.174.1.23
Zobrazit plný text záznamu
6
[Untitled]
Autor: Peter J. Weiden, William M. Glazer
Publikováno v: Psychiatric Quarterly. 68:377-392
Goals: The goals of this study are 1) to determine causes and patterns of relapse for a cohort of “revolving door” schizophrenia inpatients, and 2) to assess the feasibility of starting a new psychopharmacologic intervention before discharge, eit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::09afeb56d7b097b6bac00f172f0779bb
https://doi.org/10.1023/a:1025499131905
Zobrazit plný text záznamu
7
Psychometric properties of a decision-support tool for the era of managed care
Autor: William M. Glazer, Geoffrey V. Gray
Publikováno v: The Journal of Mental Health Administration. 23:226-233
This article reports psychometric properties of a decision-support scale designed to quantify the decision-making process for allocating psychiatric care. The authors developed a scale to evaluate the level of care needed for patients requiring psych
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdb1dee95b01ce68ee928a13425af010
https://doi.org/10.1007/bf02519113
Zobrazit plný text záznamu
8
The impact of managed care systems on relapse prevention and quality of life for patients with schizophrenia
Autor: William M. Glazer
Publikováno v: European Neuropsychopharmacology. 6:35-39
In general clinical practice relapse rates for patients with schizophrenia are worse than well-controlled studies suggest are achievable. This paper discusses the reasons for this shortfall and suggests that properly delivered “managed care” coul
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd7d61b4e12c47934d2b463e664f94b6
https://doi.org/10.1016/0924-977x(96)00009-0
Zobrazit plný text záznamu
9
Positive and Negative Symptom Course in Chronic Community-Based Patients
Autor: David Schuldberg, Donald M. Quinlan, Hal Morgenstern, William M. Glazer
Publikováno v: British Journal of Psychiatry. 166:634-641
BackgroundThe long-term symptom profile of chronic out-patients was studied.Method. 242 out-patients receiving neuroleptic medications (109 with schizophrenia and 133 non-schizophrenics), were studied for positive (SAPS) and negative (SANS) symptoms
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b84ff3d4a3f634ff6bc7896f91085a11
https://doi.org/10.1192/bjp.166.5.634
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje